Sacrosidase
From Wikipedia, the free encyclopedia
Clinical data | |
---|---|
AHFS/Drugs.com | monograph |
Legal status | ? |
Identifiers | |
ATC code | A16AB06 |
UNII | 8A7F670F2Y |
ChEMBL | CHEMBL1201487 |
Chemical data | |
Formula | ? |
(what is this?) (verify) | |
Sacrosidase (trade name Sucraid) is a medication used to replace sucrase in people lacking this enzyme.[1] It is available as an oral solution.
References
- ↑ Treem WR, McAdams L, Stanford L, Kastoff G, Justinich C, Hyams J (1999). "Sacrosidase therapy for congenital sucrase-isomaltase deficiency". J. Pediatr. Gastroenterol. Nutr. 28 (2): 137–142. doi:10.1097/00005176-199902000-00008. PMID 9932843.
External links
Sucraid Oral Solution helps relieve the gastrointestinal symptoms that are associated with CSID (Congenital Sucrase-Isomaltase deficiency).
|
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.